TL;DR: A 2026 randomized phase 2b trial in Journal of Clinical Psychopharmacology found that the PDE10A inhibitor MK-8189 did not improve Positive and Negative Syndrome Scale (PANSS) schizophrenia symptom scores more than placebo after 6 weeks, while risperidone separated from placebo in the same trial. Key Findings 458 treated participants: The acute phase included 132 …
TL;DR: A 2026 study in Neuropsychopharmacology used CRISPR gene editing in human microglia-like cells and found that several schizophrenia-linked genes changed phagocytosis, cell shape, and immune-transcription programs. Key Findings Schizophrenia-linked microglia genes were testable: The screen focused on 30 genes predicted from postmortem transcriptomic data and microglial biology to affect phagocytosis pathways. CYFIP1, MSR1, TREM2, …
TL;DR: A 2026 qualitative analysis in PLOS One used 505 ME/CFS memorial entries to map how systemic neglect, clinical dismissal, social isolation, and personal burden appeared in accounts of illness and death. Key Findings 505 memorial entries: The analysis used the National CFIDS Foundation memorial list, downloaded in October 2024. 4 theme layers: Themes were …
TL;DR: A 2026 study in Neurology found that higher autonomic symptom burden in moderate-advanced dementia with Lewy bodies was linked to worse cognitive fluctuations, higher neuropsychiatric burden, and lower caregiver quality of life over time. Key Findings Autonomic burden was measured longitudinally across 189 people with moderate-advanced dementia with Lewy bodies. Higher Autonomic Symptom Checklist …
TL;DR: A 2026 analysis in Journal of Korean Medical Science identified PIK3CG, PRKCD, and TRIM22 as glioblastoma gene markers linked to worse survival and stronger immune-activity signals in IDH-wildtype tumors. Key Findings 12,041-gene screen: Researchers screened tumor expression data to find genes tied to both poor prognosis and immune activation in grade IV glioma. 775 …
TL;DR: A pilot cohort study in JMIR Rehabilitation and Assistive Technologies found that online emotional training after facial palsy surgery improved facial movement, social well-being, and anxiety about as much as in-person therapy in 16 adults. Key Findings Population: The study followed 16 adults after triple innervation surgery for unilateral peripheral facial nerve palsy. Delivery: …
TL;DR: A 2026 functional MRI (fMRI) study in Psychological Medicine found that schizophrenia, bipolar disorder, and major depressive disorder shared some thalamus connectivity disruption, but each diagnosis showed a different subcortical network pattern across the thalamus, striatum, hippocampus, and amygdala. Key Findings 800-person MRI cohort: Researchers analyzed resting-state fMRI from 200 people with schizophrenia, 200 …
TL;DR: A 2026 randomized trial in Archives of Disease in Childhood: Fetal and Neonatal Edition found that extended caffeine therapy reduced intermittent hypoxia, brief repeated oxygen-desaturation episodes, in very preterm infants through 41 weeks postmenstrual age. Key Findings 160 infants randomized: The ICAF trial assigned 78 infants to placebo and 82 infants to extended caffeine …
TL;DR: A 2026 placebo-controlled study in Human Psychopharmacology: Clinical and Experimental found that ebselen did not meaningfully reduce motor impulsivity, reflection impulsivity, delay discounting, or emotion-recognition outcomes in 130 healthy adults. Key Findings 130 adults analyzed: The double-blind study compared 66 adults assigned to ebselen with 64 assigned to placebo. 1800 mg over 2 days: …
TL;DR: A 2026 study in Psychological Medicine found that cognitive reserve in non-affective first-episode psychosis was higher with greater genetic predisposition to educational attainment and lower with earlier psychosis onset or family history of psychosis. Key Findings 174 first-episode patients: Researchers analyzed people with non-affective first-episode psychosis, with a mean age of 25.5 years. Educational-attainment …
